
Johnson & Johnson and Purdue Pharma have settled separate lawsuits with the US state of Kentucky for a total of …

Johnson & Johnson is set to pay up to $4 billion to settle thousands of legal cases related to patients …

Johnson & Johnson has admitted promoting its big-selling antipsychotic drug Risperdal off-label, costing the firm $2.2 billion in fines. The …


Johnson & Johnson has reported a 6.5% year-on-year sales increase to $17.1 billion in the third quarter of 2012, a …
Johnson & Johnson has just released its Q2 figures showing sales fell back in the second quarter, a 3.5% growth …

A US judge has slapped a $1.19 billion fine on Johnson & Johnson after it was found to be downplaying …

Johnson & Johnson will pay more than $1 billion in the US to resolve a civil investigation into the marketing …
Janssen Pharmaceuticals has reached a partial agreement with the US government over a criminal investigation into the marketing of Risperdal. …
Janssen-Cilag has called in Virgo Health and Open Road to help boost the fortunes of its injectable antipsychotic drug Risperdal …